# UK Cardiac Monitoring Devices Market

> UK Cardiac Monitoring Devices Market Research Report Information By Product Type (ECG Monitors, Event Recorder, Implantable Cardiac Loop Recorder, Pacemaker, Defibrillator, Cardiac Resynchronization Therapy (CRT) Devices, Smart Wearable, and Other), By End User (Hospitals and Clinics, Home Care Settings, and Others) –Market Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.01%
- **2024:** $ 116.55 Million
- **2025:** $ 121.72 Million
- **2035:** $ 179.62 Million
- **Key Players:** Edwards Lifesciences (GB), Philips (GB), LiDCO Group (GB), Getinge (GB), Cheetah Medical (GB), Deltex Medical (GB), PULSION Medical Systems (GB), Nihon Kohden (GB)

**Report ID:** MRFR/MED/16253-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/uk-cardiac-monitoring-devices-market-17781

---

## Market Summary

## **UK Cardiac Monitoring Devices Market Overview**

The cardiac monitoring devices market industry is projected to grow from Significant Value by 2032, exhibiting a compound annual growth rate (CAGR) of 7.50% during the forecast period (2023 - 2032). Increasing prevalence of cardiovascular diseases, technological advancements, growing demand for home-based monitoring, rising healthcare expenditure, and government initiatives are the main market drivers anticipated to propel the cardiac monitoring devices market in the United Kingdom.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Cardiac Monitoring Devices Market Trends**

The increasing prevalence of cardiovascular diseases is a major growth driver for the UK Cardiac Monitoring Devices Market. Cardiovascular diseases refer to a group of conditions that affect the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and others. These conditions are a leading cause of morbidity and mortality in the UK, with an estimated 7.4 million people living with cardiovascular disease in the country. The prevalence of cardiovascular diseases is increasing in the UK for several reasons. First, the UK has an aging population, and age is a major risk factor for cardiovascular diseases.

As the population ages, the number of people living with cardiovascular diseases is expected to increase. Second, lifestyle factors such as poor diet, lack of exercise, and smoking are contributing to the rise in cardiovascular diseases. These lifestyle factors can increase the risk of developing cardiovascular diseases, particularly in younger adults.

Furthermore, the growing demand for home-based monitoring is another important growth driver for the UK Cardiac Monitoring Devices Market. Home-based monitoring refers to the use of cardiac monitoring devices that can be used by patients in their own homes, providing real-time data on heart health that can be transmitted to healthcare providers for analysis. There are several factors driving the growing demand for home-based monitoring in the UK. First, home-based monitoring can provide patients with more frequent and convenient monitoring of their heart health, enabling them to detect and manage cardiovascular diseases earlier.

This can improve patient outcomes and reduce healthcare costs by preventing hospitalizations and other costly interventions. Second, home-based monitoring can help reduce the burden on healthcare providers by enabling remote monitoring of patients' heart health. This can help healthcare providers detect and manage cardiovascular diseases earlier, reducing the need for costly interventions and improving patient outcomes. Finally, advances in technology have made home-based monitoring more accessible and affordable for patients. Wearable devices, such as smartwatches and fitness trackers, can provide real-time data on heart health that can be transmitted to healthcare providers for analysis.

This has made home-based monitoring more convenient and accessible for patients, driving demand for these devices in the UK.

## **Cardiac Monitoring Devices Market Segment Insights**

### **Cardiac Monitoring Devices Product Type Insights**

The UK cardiac monitoring devices market segmentation, based on product type includes ECG Monitors, Event Recorder, Implantable Cardiac Loop Recorder, [Pacemaker](../../../reports/pacemaker-market-1587), Defibrillator, Cardiac Resynchronization Therapy (CRT) Devices, Smart Wearable, and Other. The ECG monitors segment dominated the market mostly. This is due to the widespread use of ECG monitors in hospitals, clinics, and home settings for diagnosing and monitoring various cardiac conditions. The report also notes that the smart wearable segment is expected to grow at a significant rate in the coming years, driven by increasing adoption of wearable technology for fitness and healthcare tracking.

### **Cardiac Monitoring Devices End User Insights**

The UK cardiac monitoring devices market segmentation, based on end user, includes Hospitals and Clinics, Home Care Settings, and Others. The hospitals and clinics category generated the most income. This is due to the high prevalence of cardiac diseases in the UK population, which drives the demand for advanced cardiac monitoring devices in hospital and clinic settings. The report notes that the home care settings segment is also expected to grow at a significant rate in the coming years, driven by increasing preference for home-based healthcare and remote monitoring solutions.

**Figure 1: UK Cardiac Monitoring Devices Market, by End User, 2022 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Cardiac Monitoring Devices Country Insights**

With the increasing preference for home-based healthcare and remote monitoring solutions, the demand for smart wearable devices and other remote monitoring solutions is expected to grow in the UK cardiac monitoring devices market. Additionally, the UK has a well-developed healthcare infrastructure, which supports the adoption of advanced cardiac monitoring devices in hospitals, clinics, and home care settings. It is a hub for innovation and technological advancements in healthcare, which is expected to drive the development of advanced cardiac monitoring devices in the coming years.

Also, the United Kingdom has an aging population, which is expected to drive the demand for cardiac monitoring devices in the coming years. This is because elderly individuals are more prone to cardiac diseases and require regular monitoring of their heart health.

**Cardiac Monitoring Devices Key Market Players & Competitive Insights**

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the cardiac monitoring devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, cardiac monitoring devices industry must offer cost-effective items.

Major players in the cardiac monitoring devices market are attempting to increase market demand by investing in research and development operations includes Medtronic PLC; Abbott Laboratories; Boston Scientific Corporation, GE Healthcare; iRhythm Technologies, Inc.; Biotronik, Livanova PLC, Baxter (Hill-Rom Holdings, Inc); Schiller AG; Koninklijke Philips N.V. (Biotelemetry).

**Key Companies in the cardiac monitoring devices market include**

**Cardiac Monitoring Devices Industry Developments**

**2020:**Biotronik acquired Cardiofocus, a US-based developer of advanced mapping and ablation technologies for the treatment of atrial fibrillation. This acquisition is expected to expand Biotronik's product portfolio in the cardiac monitoring and treatment market.

**2019:**Abbott launched its Confirm Rx insertable cardiac monitor in the UK. The device is the world's first smartphone-compatible cardiac monitor and is designed to help physicians monitor patients with arrhythmias.

## **Cardiac Monitoring Devices Market Segmentation**

### **Cardiac Monitoring Devices Product Type Outlook**

### **Cardiac Monitoring Devices End User Outlook**

## Market Drivers

### Increased Healthcare Expenditure

The rise in healthcare expenditure in the UK is a significant factor influencing the UK Cardiac Output Monitoring Device Market. The UK government has committed to increasing the NHS budget, which is projected to reach over 200 billion GBP by 2024. This increase in funding allows for the procurement of advanced medical devices, including cardiac output monitoring systems. Furthermore, the emphasis on improving patient care and outcomes has led to greater investment in innovative technologies. As healthcare facilities upgrade their equipment to meet modern standards, the demand for cardiac output monitoring devices is expected to grow. This trend indicates a positive outlook for the UK Cardiac Output Monitoring Device Market, as financial resources are allocated towards enhancing cardiovascular care.

### Regulatory Support and Guidelines

Regulatory support and clear guidelines are essential drivers for the UK Cardiac Output Monitoring Device Market. The Medicines and Healthcare products Regulatory Agency (MHRA) plays a pivotal role in ensuring the safety and efficacy of medical devices in the UK. The establishment of streamlined approval processes for innovative cardiac monitoring technologies has encouraged manufacturers to invest in the market. Additionally, the UK government has implemented policies that promote the adoption of advanced medical devices within the NHS. This regulatory environment fosters innovation and instills confidence among healthcare providers regarding the use of cardiac output monitoring devices. As a result, the UK Cardiac Output Monitoring Device Market is likely to benefit from ongoing regulatory support, facilitating the introduction of new products and technologies.

### Growing Awareness of Preventive Healthcare

There is a notable shift towards preventive healthcare in the UK, which is significantly impacting the UK Cardiac Output Monitoring Device Market. Public health campaigns and educational initiatives have raised awareness about the importance of early detection and management of cardiovascular diseases. As individuals become more informed about their health, there is a growing demand for monitoring devices that facilitate proactive health management. The NHS has also been promoting preventive measures, encouraging patients to engage in regular health check-ups. This cultural shift towards prevention is likely to drive the adoption of cardiac output monitoring devices, as healthcare providers seek to equip patients with the tools necessary for effective self-management. Consequently, the UK Cardiac Output Monitoring Device Market is poised for growth as preventive healthcare becomes a priority.

### Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases in the UK is a primary driver for the UK Cardiac Output Monitoring Device Market. According to the British Heart Foundation, cardiovascular diseases account for a significant proportion of deaths in the UK, with approximately 160,000 fatalities annually. This alarming statistic underscores the urgent need for effective monitoring solutions. As healthcare providers seek to enhance patient outcomes, the demand for cardiac output monitoring devices is expected to rise. The National Health Service (NHS) has also recognized the importance of early detection and management of heart conditions, further propelling the market. Consequently, the UK Cardiac Output Monitoring Device Market is likely to experience substantial growth as healthcare systems prioritize cardiovascular health.

### Technological Innovations in Monitoring Devices

Technological advancements play a crucial role in shaping the UK Cardiac Output Monitoring Device Market. Innovations such as non-invasive monitoring techniques and portable devices have emerged, enhancing the accuracy and convenience of cardiac assessments. For instance, the introduction of advanced sensors and algorithms has improved the precision of cardiac output measurements. The UK government has been supportive of research and development initiatives aimed at fostering innovation in medical technology. As a result, the market is witnessing a surge in the adoption of state-of-the-art devices that offer real-time monitoring capabilities. This trend is expected to continue, as healthcare providers increasingly seek to integrate cutting-edge technology into their practices, thereby driving the growth of the UK Cardiac Output Monitoring Device Market.

## Future Outlook

The UK Cardiac Output Monitoring Device Market is projected to grow at 4.01% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditure.

**New opportunities:**

- Development of portable monitoring devices for home care settings. Integration of AI analytics for real-time patient data interpretation. Expansion into telemedicine platforms for remote patient monitoring.

By 2035, the market is expected to be robust, driven by innovation and increased demand.

## Segment Insights

### By Application: Critical Care (Largest) vs. Cardiac Surgery (Fastest-Growing)

In the UK Cardiac Output Monitoring Device Market, the application segments reveal varied distributions in market share. Critical Care constitutes the largest portion, with a significant reliance on these devices to monitor patients' vital signs in intensive care units. Cardiac Surgery, while holding a smaller market share, presents a compelling opportunity due to its increasing adoption in surgical interventions where precise cardiac output measurements are crucial for patient outcomes. The growth trends within these segments highlight shifting priorities towards enhanced patient monitoring in acute settings. Critical Care remains stable as hospitals focus on managing complex cases, but cardiac surgery is quickly gaining traction as advancements in technology and techniques improve surgical outcomes. The rising demand for real-time data in surgical procedures is propelling this segment forward, showcasing its potential for robust growth in the coming years.

Critical Care (Dominant) vs. Anesthesia (Emerging)

In the UK Cardiac Output Monitoring Device Market, Critical Care holds a dominant position, characterized by its essential role in monitoring critically ill patients. This segment is marked by a high demand for reliable and accurate data to make immediate clinical decisions in intensive care units. Conversely, Anesthesia is an emerging segment, gaining relevance as clinical practices evolve toward a more data-driven approach. With advancements in anesthetic monitoring technologies, there is an increasing emphasis on integrated devices that provide comprehensive information during surgical procedures. As healthcare providers recognize the importance of hemodynamic monitoring during anesthesia, this segment is poised for growth, reflecting a shift towards improved patient safety and surgical outcomes.

### By End Use: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the UK Cardiac Output Monitoring Device Market, hospitals dominate the end-use segment, accounting for a significant share of the total market. This is attributed to the high demand for advanced monitoring equipment in critical care settings, where accurate cardiac output measurement is crucial for patient management. Ambulatory surgical centers and specialty clinics hold a smaller yet important portion of the market, focusing on precise monitoring requirements during surgical interventions and specialized care, respectively. Looking ahead, the end-use segment is witnessing notable growth trends, driven primarily by the increasing prevalence of cardiovascular diseases and an aging population. Home care settings are emerging as the fastest-growing segment due to advancements in telehealth technologies and a shift towards more patient-centric care models. This trend is further supported by healthcare policies encouraging outpatient care and remote patient monitoring, making cardiac output monitoring more accessible outside traditional hospital environments.

Hospitals: Dominant vs. Home Care Settings: Emerging

Hospitals currently serve as the dominant end-use segment for cardiac output monitoring devices in the UK, primarily due to their extensive infrastructure for critical care and advanced medical capabilities. These facilities require high-precision devices to ensure optimal patient outcomes, particularly for individuals with serious cardiac conditions. Conversely, home care settings are classified as emerging in this market. The shift towards home healthcare is supported by technological advancements in portable monitoring devices, which allow for continuous patient oversight in a non-hospital environment. The growing preference for home care is driven by factors such as increasing healthcare costs, the need for close monitoring of chronic patients, and the benefits of reducing hospital stays, making it a dynamic and fast-growing segment in the cardiac output monitoring device market.

### By Technology: Invasive Monitoring (Largest) vs. Non-Invasive Monitoring (Fastest-Growing)

In the UK cardiac output monitoring device market, the segment comprises three key technology types: invasive monitoring, minimally invasive monitoring, and non-invasive monitoring. Among these, invasive monitoring holds the largest share due to its widespread use in critical care settings and its ability to provide accurate and continuous measurements of cardiac output. Non-invasive monitoring, with its growing adoption in outpatient and home care settings, is quickly gaining traction, making significant inroads into the market traditionally dominated by invasive solutions.

Monitoring Technology: Invasive (Dominant) vs. Non-Invasive (Emerging)

Invasive monitoring has long been the dominant technology in cardiac output monitoring, favored in hospitals for its precision and real-time data delivery, which is crucial during surgeries and in intensive care units. This method involves catheter insertion, allowing for direct measurement of cardiac output from the heart. Conversely, non-invasive monitoring is emerging as a preferred option thanks to advances in technology, enabling accurate cardiac output assessment without the need for surgical procedures. Its appeal lies in ease of use, safety, and the growing trend toward patient-centered care, accommodating users in various settings. This technology's rapid development and positive patient outcomes are thus driving its market growth in the UK.

### By Patient Type: Adult Patients (Largest) vs. Pediatric Patients (Fastest-Growing)

In the UK Cardiac Output Monitoring Device Market, adult patients represent the most significant segment due to the higher prevalence of cardiovascular diseases among this demographic. Their substantial market share is driven by the increasing demand for accurate monitoring in various healthcare settings, including hospitals and outpatient clinics. In contrast, the pediatric patient segment showcases remarkable growth, reflecting advancements in technology specifically tailored for young patients, thereby enhancing their overall monitoring experience.

Adult Patients (Dominant) vs. Pediatric Patients (Emerging)

The adult patient segment is characterized by its dominance in the UK Cardiac Output Monitoring Device Market, attributed to the growing aging population and the rising incidence of chronic heart conditions. These devices are essential for managing critical care in adults, ensuring timely interventions and better patient outcomes. On the other hand, the pediatric patient segment is emerging swiftly, driven by innovations in device design and functionality specifically intended for younger patients. This niche market provides significant opportunities as healthcare providers increasingly recognize the need for specialized monitoring solutions that cater to the unique physiological characteristics of children.

## Competitive Benchmarking

The Cardiac Output Monitoring Device Market in the UK is characterized by a competitive landscape that is increasingly shaped by technological advancements and strategic collaborations. Key growth drivers include the rising prevalence of cardiovascular diseases, an aging population, and the growing emphasis on patient-centric care. Major players such as Edwards Lifesciences (GB), Philips (GB), and LiDCO Group (GB) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Edwards Lifesciences (GB) focuses on developing advanced hemodynamic monitoring solutions, while Philips (GB) emphasizes digital health technologies to improve patient outcomes. LiDCO Group (GB) is known for its cost-effective monitoring solutions, which appeal to a broad range of healthcare facilities, thereby collectively shaping a competitive environment that prioritizes innovation and patient care.
In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players vying for market share. This fragmentation allows for diverse offerings and competitive pricing, although the influence of key players remains significant in setting industry standards and driving technological advancements.
In December 2025, Edwards Lifesciences (GB) announced the launch of its latest hemodynamic monitoring system, which integrates AI-driven analytics to provide real-time insights into cardiac performance. This strategic move is likely to enhance patient management and improve clinical outcomes, positioning the company as a leader in innovative cardiac monitoring solutions. The integration of AI not only streamlines data interpretation but also supports clinicians in making informed decisions, thereby reinforcing Edwards Lifesciences' commitment to advancing patient care.
In November 2025, Philips (GB) expanded its partnership with a leading UK hospital network to implement its advanced cardiac monitoring systems across multiple facilities. This collaboration aims to enhance the quality of care through integrated health solutions and demonstrates Philips' focus on digital transformation in healthcare. By aligning with healthcare providers, Philips (GB) is likely to strengthen its market position and foster innovation in cardiac care, ultimately benefiting patient outcomes.
In October 2025, LiDCO Group (GB) secured a significant contract with a major NHS trust to supply its cardiac output monitoring devices. This contract underscores the growing recognition of LiDCO's cost-effective solutions in the public healthcare sector. By establishing strong ties with NHS trusts, LiDCO Group (GB) is poised to expand its market reach and reinforce its reputation as a provider of reliable and affordable monitoring technologies.
As of January 2026, current competitive trends in the Cardiac Output Monitoring Device Market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and enhanced patient outcomes. This shift suggests that companies that prioritize innovation and strategic partnerships will be better positioned to thrive in the dynamic market environment.

## Recent News & Developments

**2020:**Biotronik acquired Cardiofocus, a US-based developer of advanced mapping and ablation technologies for the treatment of atrial fibrillation. This acquisition is expected to expand Biotronik's product portfolio in the cardiac monitoring and treatment market.

**2019:**Abbott launched its Confirm Rx insertable cardiac monitor in the UK. The device is the world's first smartphone-compatible cardiac monitor and is designed to help physicians monitor patients with arrhythmias.

## Report Scope

| MARKET SIZE 2024 | 116.55(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 121.72(USD Million) |
| MARKET SIZE 2035 | 179.62(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.01% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Edwards Lifesciences (GB), Philips (GB), LiDCO Group (GB), Getinge (GB), Cheetah Medical (GB), Deltex Medical (GB), PULSION Medical Systems (GB), Nihon Kohden (GB) |
| Segments Covered | Application, End Use, Technology, Patient Type |
| Key Market Opportunities | Integration of advanced analytics and artificial intelligence in the UK Cardiac Output Monitoring Device Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in the UK Cardiac Output Monitoring Device Market. |
| Countries Covered | UK |

## Frequently Asked Questions

**Q: What is the current valuation of the UK Cardiac Output Monitoring Device Market?**
A: As of 2024, the market valuation was 116.55 USD Million.

**Q: What is the projected market size for the UK Cardiac Output Monitoring Device Market by 2035?**
A: The market is projected to reach 179.62 USD Million by 2035.

**Q: What is the expected CAGR for the UK Cardiac Output Monitoring Device Market during the forecast period?**
A: The expected CAGR for the market from 2025 to 2035 is 4.01%.

**Q: Which applications are driving growth in the UK Cardiac Output Monitoring Device Market?**
A: Key applications include Critical Care, which had a valuation of 30.0 to 45.0 USD Million, and Anesthesia, valued at 25.0 to 35.0 USD Million.

**Q: What are the primary end-use segments in the UK Cardiac Output Monitoring Device Market?**
A: The primary end-use segments include Hospitals, with a valuation of 40.0 to 60.0 USD Million, and Specialty Clinics, valued at 31.55 to 49.62 USD Million.

**Q: How does the technology segment break down in the UK Cardiac Output Monitoring Device Market?**
A: The technology segment includes Invasive Monitoring, valued at 40.0 to 60.0 USD Million, and Non-Invasive Monitoring, which ranges from 41.55 to 69.62 USD Million.

**Q: What patient types are primarily targeted in the UK Cardiac Output Monitoring Device Market?**
A: The market targets Adult Patients, with a valuation of 70.0 to 108.0 USD Million, and Pediatric Patients, valued at 25.0 to 40.0 USD Million.

**Q: Who are the key players in the UK Cardiac Output Monitoring Device Market?**
A: Key players include Edwards Lifesciences, Philips, and LiDCO Group, among others.

**Q: What is the significance of postoperative care in the UK Cardiac Output Monitoring Device Market?**
A: Postoperative Care is valued between 26.55 and 44.62 USD Million, indicating its relevance in the market.

**Q: How does the market for home care settings compare to other end-use segments?**
A: Home Care Settings are valued at 20.0 to 30.0 USD Million, which is lower than Hospitals and Specialty Clinics.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-cardiac-monitoring-devices-market-17781*